AP-306

· Alebund Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AP-306, covering 2024-01-10 to 2024-01-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia Patients [Phase 2]